Treatment With Interleukin-6 Inhibitors Reduces Risk Of Death By 75% Compared To Standard Treatment Among Patients With COVID-19, Systematic Review And Meta-Analysis Find

Infectious Disease Advisor (5/4, Mermelstein) reports “treatment with interleukin-6 (IL-6) inhibitors decreased the risk of death among patients with COVID-19 infection by 75% compared with standard treatment, according to results of” an 11-study systemat...